LGD2941

DB05234ExperimentalSmall molecule

LGD2941 is a non-steroidal, selective androgen receptor modulator (SARM) developed jointly by Ligand and TAP.

Mechanism: LGD2941 selectively modulates the activity of the androgen receptor (AR) in different tissues.
Curator reviewed
Primary indication: For the treatment and prevention of osteoporosis.Curator reviewed
Formula / weight: C₁₇H₁₆F₆N₂O₂ · 394.3116 g/mol (avg)
Code names: LGD2941

Resolves to

Compound

Structure

InChIKeyHWLLYFXDDGGHOE-BCSUUIJWSA-NSMILESC[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with LGD2941, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.